US Biologics Safety Testing Market: Growth in Biopharma Innovations - Forecast 2032 United StatesThe United States biologics safety testing market due to its well-established biopharmaceutical industry, strong regulatory support from the FDA, and advanced research facilities. The growing production of biologics, including vaccines and cell therapies, further drives the demand for safety testing solutions in the country.
GermanyGermany is a key contributor to the...
0 Distribuiri
14 Views
0 previzualizare